Tuesday, January 14, 2025 11:19:30 AM
Believe it or not, NWBO has been consistent with the vast majority of other companies when it comes to communications around this process
That was not quiet the point FeMike was making read this again:
1. NWBO: " We will not update anyone on anything throughout the entire process. It's simply not allowed. That is how all other companies do it, so that is how we will do it"
2. Other (or according to you some) Companies: "Here's every, (or according to you SOME) updates we can give shareholders on the status with every RA every step of the way, and our guess as to when things will happen, yay stock price.
You are now nitpicking if some other biotechs in MHRA process have provided some updates or all updates and if all companies in MHRA did that or only some.
The point is that Powerless lied when she said this "It's simply not allowed. . Well it is allowed so it turned out surprise, surprise. NWBO has yet again ignored many opportunities over the last 12 months to update the market not only about the MHRA process they are in but also about the incredible news they laid out in the last 10Q (restarting Direct, new combi trials, cooperation with other cancer institutions etc) which could have supported the stock price tremendously something so it seems NWBO management does not give a rats ass about. Thats what this is all about.
But hey Im sure genius Powerless has laid a huge bear trap for the shorts after MHRA approval and thats why it only seems she is incredibly incompetent, so there is that
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
